These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 23009609)
1. A woman with breast cancer and severe impaired lactose tolerance: an intriguing therapeutic dilemma. Zagouri F; Dimitrakakis C; Dimopoulos MA; Tsigginou A; Antsaklis A; Papadimitriou CA Breast J; 2012; 18(6):628-9. PubMed ID: 23009609 [No Abstract] [Full Text] [Related]
2. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524 [TBL] [Abstract][Full Text] [Related]
4. Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group. Dubsky PC; Jakesz R; Mlineritsch B; Pöstlberger S; Samonigg H; Kwasny W; Tausch C; Stöger H; Haider K; Fitzal F; Singer CF; Stierer M; Sevelda P; Luschin-Ebengreuth G; Taucher S; Rudas M; Bartsch R; Steger GG; Greil R; Filipcic L; Gnant M J Clin Oncol; 2012 Mar; 30(7):722-8. PubMed ID: 22271481 [TBL] [Abstract][Full Text] [Related]
5. Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer. Dowsett M; Pfister C; Johnston SR; Miles DW; Houston SJ; Verbeek JA; Gundacker H; Sioufi A; Smith IE Clin Cancer Res; 1999 Sep; 5(9):2338-43. PubMed ID: 10499602 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer. Ingle JN; Suman VJ; Johnson PA; Krook JE; Mailliard JA; Wheeler RH; Loprinzi CL; Perez EA; Jordan VC; Dowsett M Clin Cancer Res; 1999 Jul; 5(7):1642-9. PubMed ID: 10430063 [TBL] [Abstract][Full Text] [Related]
11. Letrozole or tamoxifen in early breast cancer. Buzdar AU; Baum M; Cuzick J N Engl J Med; 2006 Apr; 354(14):1528-30; author reply 1528-30. PubMed ID: 16598051 [No Abstract] [Full Text] [Related]
12. [New strategies against breast carcinoma. To outwit the resistance tendency of tumor cells]. Jakesz R MMW Fortschr Med; 2005 Mar; 147(10):8. PubMed ID: 15803774 [No Abstract] [Full Text] [Related]
13. Clinically occult cutaneous metastases. Resnik KS; DiLeonardo M; Gibbons G J Am Acad Dermatol; 2006 Dec; 55(6):1044-7. PubMed ID: 17110220 [TBL] [Abstract][Full Text] [Related]
14. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Baum M; Buzdar A; Cuzick J; Forbes J; Houghton J; Howell A; Sahmoud T; Cancer; 2003 Nov; 98(9):1802-10. PubMed ID: 14584060 [TBL] [Abstract][Full Text] [Related]
15. [Campaign against breast cancer. Are aromatase inhibitors the better choice? (interview by Dr. Dorothea Dlugosch)]. Bruntsch U MMW Fortschr Med; 2002 Sep; 144(38):20. PubMed ID: 12395697 [No Abstract] [Full Text] [Related]
16. Gallbladder metastases of breast cancer: from clinical-pathological patterns to diagnostic and therapeutic strategy. Di Vita M; Zanghì A; Lanzafame S; Cavallaro A; Piccolo G; Berretta M; Grosso G; Cappellani A Clin Ter; 2011; 162(5):451-6. PubMed ID: 22041804 [TBL] [Abstract][Full Text] [Related]
17. Influence of concurrent anastrozole on acute and late side effects of whole breast radiotherapy. Valakh V; Trombetta MG; Werts ED; Labban G; Khalid MK; Kaminsky A; Parda D Am J Clin Oncol; 2011 Jun; 34(3):245-8. PubMed ID: 20622644 [TBL] [Abstract][Full Text] [Related]
18. The differences in outcome between ATAC and BIG 1-98 suggest efficacy differences between these two nonsteroidal AIs. Mouridsen HT Cancer Invest; 2010; 28 Suppl 1():1-3. PubMed ID: 20653402 [No Abstract] [Full Text] [Related]
19. Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial. Pfeiler G; Königsberg R; Fesl C; Mlineritsch B; Stoeger H; Singer CF; Pöstlberger S; Steger GG; Seifert M; Dubsky P; Taucher S; Samonigg H; Bjelic-Radisic V; Greil R; Marth C; Gnant M J Clin Oncol; 2011 Jul; 29(19):2653-9. PubMed ID: 21555684 [TBL] [Abstract][Full Text] [Related]
20. Anastrozole for breast cancer: recent advances and ongoing challenges. Buzdar AU Expert Rev Anticancer Ther; 2006 Jun; 6(6):839-48. PubMed ID: 16761927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]